Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignancies, Hematologic”

14,299 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 14,299 results

Testing effectiveness (Phase 2)UnknownNCT00354276
What this trial is testing

VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Vion Pharmaceuticals 85
Not applicableNot Yet RecruitingNCT07493018
What this trial is testing

Effect of Hand Puppet and Squeeze Toys on IV Placement in Pediatric Oncology Patients

Who this might be right for
Pediatric HematologyPediatric Oncology
Akdeniz University 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT04734990
What this trial is testing

Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Who this might be right for
Chronic Myelomonocytic Leukemia-0Chronic Myelomonocytic Leukemia-1Chronic Myelomonocytic Leukemia-2+3 more
M.D. Anderson Cancer Center 24
Large-scale testing (Phase 3)Study completedNCT00003190
What this trial is testing

Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+12 more
National Cancer Institute (NCI) 640
Early research (Phase 1)Looking for participantsNCT06708897
What this trial is testing

Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies

Who this might be right for
CLL / SLLCLL (Chronic Lymphocytic Leukemia)SLL (Small Lymphocytic Lymphoma)+2 more
Lomond Therapeutics Holdings, Inc. 84
Not applicableLooking for participantsNCT05022446
What this trial is testing

The Impact of COVID-19 on Pulmonary Procedures

Who this might be right for
COVID-19 InfectionHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
M.D. Anderson Cancer Center 250
Testing effectiveness (Phase 2)Study completedNCT00040846
What this trial is testing

Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+97 more
Fred Hutchinson Cancer Center 60
Large-scale testing (Phase 3)UnknownNCT00003603
What this trial is testing

Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Riverside Haematology Group 660
Not applicableUnknownNCT05609227
What this trial is testing

Effect of Mobile Application on Supportive Care Needs and Quality of Life Patients Undergoing Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematologic MalignancyPatient Education
Baskent University 36
Testing effectiveness (Phase 2)Study completedNCT02061761
What this trial is testing

Evaluate the Safety, Tolerability, and Efficacy of Relatlimab in Relapsed or Refractory B-Cell Malignancies

Who this might be right for
Hematologic Neoplasms
Bristol-Myers Squibb 106
Not applicableLooking for participantsNCT06727942
What this trial is testing

Virtual Reality-Infused Treadmill Training on Aging-Related Outcomes

Who this might be right for
Adult ALL
The University of Texas at Arlington 60
Not applicableUnknownNCT02757586
What this trial is testing

Treatment of Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
Peking University People's Hospital 70
Not applicableUnknownNCT01953770
What this trial is testing

Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2008

Who this might be right for
Childhood Acute Lymphoblastic Leukemia
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 3,000
Not applicableUnknownNCT03075969
What this trial is testing

Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 337
Early research (Phase 1)Temporarily pausedNCT06802523
What this trial is testing

Testing the Combination of Targeted Radiotherapy With Anti-Cancer Drugs, Venetoclax and ASTX-727, to Improve Outcomes for Adults With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
National Cancer Institute (NCI) 53
Testing effectiveness (Phase 2)UnknownNCT02660762
What this trial is testing

Modified MRCUKALLⅫ/ECOGE2993 Regimen for ALL

Who this might be right for
Leukaemia,Lymphoblastic
Sun Yat-sen University 100
Testing effectiveness (Phase 2)Study completedNCT00940342
What this trial is testing

Rituximab Plus Sargramostim (GM-CSF) In Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 130
Testing effectiveness (Phase 2)Ended earlyNCT00020969
What this trial is testing

Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
CTI BioPharma
Early research (Phase 1)Looking for participantsNCT07586618
What this trial is testing

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

Who this might be right for
Lymphoblastic LymphomaAcute Lymphoblastic Leukemia ALL
Allterum Therapeutics, Inc 24
Testing effectiveness (Phase 2)Study completedNCT00006390
What this trial is testing

Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
Eastern Cooperative Oncology Group
Next Page